CD44 and neoplasm: Specific markers such as OCT4, SOX2, NANOG, ALDH1, and CD44 are commonly used to identify CSCs, with CD44 glycoprotein being the most widely recognized due to its correlation with higher tumor grades and later clinical stages [5].